DIVERSITY OF V3 REGION SEQUENCES OF HUMAN IMMUNODEFICIENCY VIRUSES TYPE-1 FROM THE CENTRAL-AFRICAN-REPUBLIC

被引:126
作者
MURPHY, E
KORBER, B
GEORGESCOURBOT, MC
YOU, B
PINTER, A
COOK, D
KIENY, MP
GEORGES, A
MATHIOT, C
BARRESINOUSSI, F
GIRARD, M
机构
[1] LOS ALAMOS NATL LAB,LOS ALAMOS,NM 87545
[2] SANTA FE INST,SANTA FE,NM 87501
关键词
D O I
10.1089/aid.1993.9.997
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Nucleotide sequences of the central portion of gp120, including the third hypervariable (V3) loop, were obtained from lymphocytes cocultivated with SupT1 cells from 29 AIDS patients in Bangui, Central African Republic. These sequences displayed significantly greater diversity (average distance, 23%) than has been previously observed in isolates from comparably restricted geographical areas. Isolates belonging to four major subtypes of HIV-1 were found; the only subtype not represented was the North American/European subtype B. Unlike the situation in Zaire and Uganda, where subtypes A and D account equally for virtually all isolates of HIV-1, the predominant subtypes in the Central African Republic, accounting for two-thirds of the isolates, were subtypes A (10 isolates) and E (9 isolates). Subtype E represents a group of variants that have previously been found only in Thailand. Only one isolate belonging to subtype D was found. Also recovered were two isolates of subtype C, a subtype associated with southern African and Indian isolates but not previously detected in central Africa. These isolates, although clearly clustering with subtype C, formed a distinct subset, differing from one another by 8.8% and from the Indian and South African subtype C isolates by an average of 22.5%. High interpatient, intrasubtype variation was also seen among the CAR subtype A (average pairwise difference, 19.3%) and subtype E (10.9%) isolates. The diversity of V3 sequences in this set has implications for immunization protocols that rely on the recognition of V3. This study underscores the necessity of basing intervention strategies on knowledge of the particular sequences present in the target population or geographical area.
引用
收藏
页码:997 / 1006
页数:10
相关论文
共 53 条
[31]  
Moore J P, 1991, AIDS, V5 Suppl 2, pS21, DOI 10.1097/00002030-199101001-00004
[32]  
MYERS G, 1992, HUMAN RETROVIRUSES A
[33]   EMERGENCE OF VIRUSES RESISTANT TO NEUTRALIZATION BY V3-SPECIFIC ANTIBODIES IN EXPERIMENTAL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-IIIB INFECTION OF CHIMPANZEES [J].
NARA, PL ;
SMIT, L ;
DUNLOP, N ;
HATCH, W ;
MERGES, M ;
WATERS, D ;
KELLIHER, J ;
GALLO, RC ;
FISCHINGER, PJ ;
GOUDSMIT, J .
JOURNAL OF VIROLOGY, 1990, 64 (08) :3779-3791
[34]  
OLSON GJ, 1993, COMMUNICATION
[35]   SEQUENCE-ANALYSIS OF THE V3 LOOP REGIONS OF THE ENV GENES OF UGANDAN HUMAN IMMUNODEFICIENCY PROVIRUSES [J].
ORAM, JD ;
DOWNING, RG ;
ROFF, M ;
SERWANKAMBO, N ;
CLEGG, JCS ;
FEATHERSTONE, ASR ;
BOOTH, JC .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (07) :605-614
[36]  
POTTS BJ, 1993, IN PRESS VIROLOGY
[37]   HIGH-TITER HIV-1 NEUTRALIZING ANTIBODY-RESPONSE OF RHESUS MACAQUES TO GP160 AND ENV PEPTIDES [J].
RONCO, J ;
DEDIEU, JF ;
MARIE, FN ;
PINTER, A ;
KACZOREK, M ;
GIRARD, M .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (06) :1117-1123
[38]   ANTIBODIES THAT INHIBIT FUSION OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CELLS BIND A 24-AMINO ACID SEQUENCE OF THE VIRAL ENVELOPE, GP120 [J].
RUSCHE, JR ;
JAVAHERIAN, K ;
MCDANAL, C ;
PETRO, J ;
LYNN, DL ;
GRIMAILA, R ;
LANGLOIS, A ;
GALLO, RC ;
ARTHUR, LO ;
FISCHINGER, PJ ;
BOLOGNESI, DP ;
PUTNEY, SD ;
MATTHEWS, TJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (09) :3198-3202
[39]   HU-PBL-SCID MICE CAN BE PROTECTED FROM HIV-1 INFECTION BY PASSIVE TRANSFER OF MONOCLONAL-ANTIBODY TO THE PRINCIPAL NEUTRALIZING DETERMINANT OF ENVELOPE GP120 [J].
SAFRIT, JT ;
FUNG, MSC ;
ANDREWS, CA ;
BRAUN, DG ;
SUN, WNC ;
CHANG, TW ;
KOUP, RA .
AIDS, 1993, 7 (01) :15-21
[40]   SMALL AMINO-ACID CHANGES IN THE V3-HYPERVARIABLE REGION OF GP120 CAN AFFECT THE T-CELL-LINE AND MACROPHAGE TROPISM OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
SHIODA, T ;
LEVY, JA ;
CHENGMAYER, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (20) :9434-9438